Showing results (91-100 of 177) with videos related to

Sort By:
Pageof 18
Molecular Imaging and Biology|August 16, 2015
Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor HypoxiaNarges K Tafreshi, Mark C Lloyd, Joshua B Proemsey, et al.
Annals of Vascular Surgery|February 4, 2014
Sarcomas of the aorta: a systematic review and pooled analysis of published reportsChad G Rusthoven, Arthur K Liu, Marilyn M Bui, et al.
Journal of Pathology Informatics|December 29, 2025
The AI-powered pathologist: A global survey mapping initial trends in AI adoption and outlookMeredith K Herman, Sania Qazi, Elisa Farrell, et al.
Advances in Radiation Oncology|December 9, 2022
Effect of Favorable Pathologic Response After Neoadjuvant Radiation Therapy Alone in Soft-tissue SarcomaRussell F Palm, Casey L Liveringhouse, Ricardo J Gonzalez, et al.
The American Journal of Surgical Pathology|April 17, 2013
Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the boneElizabeth G Demicco, Wei-Lien Wang, John E Madewell, et al.
Human Pathology|November 1, 2008
Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literatureTaketoshi Yasuda, Kyle D Perry, Marilu Nelson, et al.
International Journal of Experimental Pathology|February 12, 2015
CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlationHamid Zia, Graeme I Murray, Carrie A Vyhlidal, et al.
Journal of the American College of Radiology : JACR|December 24, 2022
Integrative Diagnostics: The Time Is Now-A Report From the International Society for Strategic Studies in RadiologyNorman J Beauchamp, R Nick Bryan, Marilyn M Bui, et al.
Insights Into Imaging|March 30, 2023
Integrative diagnostics: the time is now-a report from the International Society for Strategic Studies in RadiologyNorman J Beauchamp, R Nick Bryan, Marilyn M Bui, et al.
Journal of the American Society of Cytopathology|August 22, 2022
Assessing ROSE for adequacy of EBUS-TBNA compared with a direct-to-cell block approach as a response to the COVID-19 pandemicXing Zhao, Paul Boothe, Syeda Mahrukh Hussnain Naqvi, et al.
Pageof 18